Additional file 1: of Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome

Halperin, Daniel; Huynh, Lynn; Beaumont, Jennifer; Cai, Beilei; Bhak, Rachel; Narkhede, Sahil; Totev, Todor; Duh, Mei; Neary, Maureen; Cella, David

doi:10.6084/m9.figshare.7915244.v1

12885_2019_5459_MOESM1_ESM.docx (28.79 kB)

Additional file 1: of Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome

journal contribution

posted on 2019-03-28, 05:00 authored by Daniel Halperin, Lynn Huynh, Jennifer Beaumont, Beilei Cai, Rachel Bhak, Sahil Narkhede, Todor Totev, Mei Duh, Maureen Neary, David Cella

Table S1. Change in Quality of Life Scores between Time Point 1 and Time Point 2: New CS-specific FACT-G Subscale. Table S2. Change in Quality of Life Scores between Time Point 1 and Time Point 2 for Participants with Carcinoid Syndrome: PROMIS-29 and FACT-G. (DOCX 28 kb)

Funding

Novartis Pharmaceuticals Corporation

History

Usage metrics

Keywords

(Limitâ=â3 to 10): carcinoid syndrome Somatostatin analogs Quality of life FACT-G Healthcare resource utilization

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome

Funding

Novartis Pharmaceuticals Corporation

History

Usage metrics

Categories

Keywords

Licence

Exports